![XPR Essential Analytical Balances: Highly accurate and fast results XPR Essential Analytical Balances: Highly accurate and fast results](https://cdn.magzter.com/1394808148/1727680168/articles/sL7PAS7t01729753406181/XPR-ESSENTIAL-ANALYTICAL-BALANCES-HIGHLY-ACCURATE-AND-FAST-RESULTS.jpg)
Introducing the XPR Essential Analytical Balances, enLgineered to deliver highly accurate and fast results with all the essential features you need for precise laboratory work. With their high-performance load cell and innovative hanging weighing pan design, these balances are perfect for weighing small samples with exceptional accuracy, ultimately reducing waste, and saving costs.
Swiss precision and durability
Manufactured in Switzerland with high-quality materials, XPR Essential balances embody the renowned durability of METTLER TOLEDO products. These balances are designed to endure intensive use, offering reliable performance and a low cost of ownership for years to come. The robust load cell and advanced electronics ensure consistent, dependable results, making these balances a longterm investment for any laboratory.
この記事は Express Pharma の October 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Express Pharma の October 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
![Pharma's strategic path to growth in the nutra maze Pharma's strategic path to growth in the nutra maze](https://reseuro.magzter.com/100x125/articles/5843/1981257/S7RL7urj51738585009245/PHARMAS-STRATEGIC-PATH-TO-GROWTH-IN-THE-NUTRA-MAZE.jpg)
Pharma's strategic path to growth in the nutra maze
The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it's a space where the allure of a $11.55 billion pie by 2030 is tempered by a maze of regulatory grey zones, stiff competition, and trust-eroding marketing practices.
![PRIME NEO from Gandhi Automations PRIME NEO from Gandhi Automations](https://reseuro.magzter.com/100x125/articles/5843/1981257/pSoWQPTC11738587385901/PRIME-NEO-FROM-GANDHI-AUTOMATIONS.jpg)
PRIME NEO from Gandhi Automations
Gandhi Automation's PRIME NEO High Speed Doors are designed to provide superior sealing and resistance to pressure differences for clean rooms. And the added advantage is that it is absolutely washable
![AI smart camera for real-time automation AI smart camera for real-time automation](https://reseuro.magzter.com/100x125/articles/5843/1981257/s351jeUlb1738587298023/AI-SMART-CAMERA-FOR-REALTIME-AUTOMATION.jpg)
AI smart camera for real-time automation
Integrated asset management functionality and a deep learning tool for training and evaluation keep productivity high and costs low
![PROSOLV® 730: Directly compressible carrier for lipophilic ingredients PROSOLV® 730: Directly compressible carrier for lipophilic ingredients](https://reseuro.magzter.com/100x125/articles/5843/1981257/6cppB9bi11738586297726/PROSOLV-730-DIRECTLY-COMPRESSIBLE-CARRIER-FOR-LIPOPHILIC-INGREDIENTS.jpg)
PROSOLV® 730: Directly compressible carrier for lipophilic ingredients
Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.
![Complete environmental monitoring solution - testo Saveris Pharma Complete environmental monitoring solution - testo Saveris Pharma](https://reseuro.magzter.com/100x125/articles/5843/1981257/TqM5z0Frt1738587594040/COMPLETE-ENVIRONMENTAL-MONITORING-SOLUTION-TESTO-SAVERIS-PHARMA.jpg)
Complete environmental monitoring solution - testo Saveris Pharma
testo Saveris Pharma monitors and documents temperature, humidity, differential pressure, and other parameters without interruption and compliantly with GxP so that audits and inspections are conducted smoothly
![The unmissable Asia healthcare opportunity The unmissable Asia healthcare opportunity](https://reseuro.magzter.com/100x125/articles/5843/1981257/FkJMEHrta1738583001800/THE-UNMISSABLE-ASIA-HEALTHCARE-OPPORTUNITY.jpg)
The unmissable Asia healthcare opportunity
BCG's latest report, The Unmissable Asia Healthcare Opportunity, highlights the region's $5 trillion healthcare market potential by 2030, driven by demographic shifts, investment, and innovation.
![2025: Healthcare and Lifesciences investment outlook 2025: Healthcare and Lifesciences investment outlook](https://reseuro.magzter.com/100x125/articles/5843/1981257/gni4wTlSk1738585367741/2025-HEALTHCARE-AND-LIFESCIENCES-INVESTMENT-OUTLOOK.jpg)
2025: Healthcare and Lifesciences investment outlook
Kapil Khandelwal, Managing Partner, Toro Finserve and EquNev Capital, interprets the possibilities for the various segments of the Indian lifesciences and healthcare sector for this year
![The group's offerings range from over a billion injection doses annually to bespoke medical machinery The group's offerings range from over a billion injection doses annually to bespoke medical machinery](https://reseuro.magzter.com/100x125/articles/5843/1981257/ytLU7DSi51738579961377/THE-GROUPS-OFFERINGS-RANGE-FROM-OVER-A-BILLION-INJECTION-DOSES-ANNUALLY-TO-BESPOKE-MEDICAL-MACHINERY.jpg)
The group's offerings range from over a billion injection doses annually to bespoke medical machinery
Rishad Dadachanji, MD, Dadachanji Group speaks on the company's evolution from a pharma packaging company to a diversified solutions provider in biotechnology, automation, and sterile processing.
![DECODING THE M&A LANDSCAPE DECODING THE M&A LANDSCAPE](https://reseuro.magzter.com/100x125/articles/5843/1981257/m9-U1Nic21738580242970/DECODING-THE-MA-LANDSCAPE.jpg)
DECODING THE M&A LANDSCAPE
Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing capabilities.
![Evolution and commercialisation of cell and gene therapies Evolution and commercialisation of cell and gene therapies](https://reseuro.magzter.com/100x125/articles/5843/1981257/6TatCW-851738582670742/EVOLUTION-AND-COMMERCIALISATION-OF-CELL-AND-GENE-THERAPIES.jpg)
Evolution and commercialisation of cell and gene therapies
Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global milestones, industry growth, and reimbursement models.